Core Scientific, Inc.
CORZQ · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $554,639 | $273,953 | $319,412 | $114,015 |
| - Cash | $50,409 | $42,146 | $57,593 | $47,487 |
| + Debt | $865,545 | $864,874 | $29,196 | $37,297 |
| Enterprise Value | $1,369,775 | $1,096,681 | $291,015 | $103,825 |
| Revenue | $141,929 | $112,904 | $126,912 | $120,655 |
| % Growth | 25.7% | -11% | 5.2% | – |
| Gross Profit | $39,300 | $15,419 | $36,959 | $20,484 |
| % Margin | 27.7% | 13.7% | 29.1% | 17% |
| EBITDA | $38,795 | -$15,027 | $49,411 | $8,873 |
| % Margin | 27.3% | -13.3% | 38.9% | 7.4% |
| Net Income | -$195,693 | -$41,146 | -$9,260 | -$11,685 |
| % Margin | -137.9% | -36.4% | -7.3% | -9.7% |
| EPS Diluted | -0.512 | -0.11 | -0.025 | -0.031 |
| % Growth | -365.5% | -347.2% | 20.9% | – |
| Operating Cash Flow | $21,703 | $5,434 | $18,035 | $19,942 |
| Capital Expenditures | -$11,638 | -$2,868 | -$949 | -$1,539 |
| Free Cash Flow | $10,065 | $2,566 | $17,086 | $18,403 |